At a glance
ClinicalIndex Comparison Record- ✓HCA Healthcare hospital admitting adults for skin and soft tissue infection
- ✓Hospital use of MEDITECH electronic health record system
- ✓Adult patients age ≥18 admitted to non-intensive care unit wards
- ✓Patients ordered to receive extended-spectrum antibiotics for skin and soft tissue infection
None specified.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The INSPIRE-ASP Trial (INtelligent Stewardship Prompts to Improve Real-Time Empiric Antibiotic Selection for Patients) for Skin and Soft Tissue (SST) Infections
In Brief
A clinical study evaluating Arm 1: Routine Care and Arm 2: INSPIRE Stewardship Bundle for Skin and Soft Tissue Infection for Skin and Soft Tissue (SST) Infection. Completed, enrolled 118,562 participants across 102 sites.
Detailed Summary
The INSPIRE Skin and Soft Tissue Infection trial is a cluster-randomized controlled trial of HCA Healthcare hospitals comparing routine empiric antibiotic stewardship practices with real-time, precision medicine computerized physician order entry (CPOE) smart prompts providing the probability that a non-critically ill adult admitted with skin and soft tissue infection is infected with a resistant pathogen. Note: enrolled "subjects" represent 102 individual HCA Healthcare hospitals that have been randomized into 92 clusters. Hospitals were grouped into the same randomization cluster if they shared campuses or antibiotic stewardship staff.
Study Details
Timeline
Interventions
Routine Antibiotic Stewardship Arm - Continuation of antibiotic stewardship activities in accordance with national standards.
Quality improvement intervention that includes (1) computerized physician order entry (CPOE) decision support alert that provides physicians with patient-specific risk estimates for having a skin/soft tissue infection due to a multidrug-resistant organism (MDRO) and recommends standard spectrum antibiotics for low risk patients in the first 3 days of hospitalization; (2) clinician feedback reports, and (3) activities to support CPOE adoption (including education and alignment of CPOE workflows). Other antibiotic stewardship activities to continue in accordance with national standards.